EP. 1: Historical Treatment Approaches for CSCC
EP. 2: Unresectable CSCC: An Improved Standard of Care
EP. 3: Impact of Data From the EMPOWER-CSCC-1 Study
EP. 4: Unresectable CSCC: Experience With Checkpoint Inhibition
EP. 5: Unresectable CSCC: Checkpoint Inhibitor Dosing & Management
EP. 6: Next Steps for Checkpoint Inhibitors in CSCC
EP. 7: Future Management of Cutaneous Squamous Cell Carcinoma
Piecing Together the Proper BTK Usage in CLL
Real-World Experience With CAR T Varies From Trials in DLBCL
TAB-Follicular Lymphoma
Dr Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors
%20(2)%201-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
